Awards/PROJECT GRANT (B)

$38,339,677

Department of State·Department of State

WORK BEGAN2025-11-25·LATEST ACTION—·SOURCEUSASPENDING·SOURCE IDASST_NON_SAQMIP26GR0017_019

Award description

TO FUND THE PURCHASE OF LENACAPAVIR FOR PREP THROUGH WAMBO.ORG FOR DOS / GHSD-FINANCED BENEFICIARIES IN PEPFAR-SUPPORTED COUNTRIES.

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Fund lenacapavir purchases for HIV prevention in PEPFAR-supported countries through a global health partnership.

Sub-sectors

foreign-aidglobal-healthhiv-prep

Why this matters

Supports U.S. global health diplomacy and HIV prevention goals in resource-limited settings aligned with PEPFAR strategic priorities.

Supply-chain signal

Indicates sustained demand for lenacapavir (Gilead Sciences product) through multilateral procurement channels in developing nations.

U.S.–China competition angle

Demonstrates U.S. commitment to global health leadership and soft power in regions where China is expanding health diplomacy.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002217.

Period of performance

Start

2025-11-25

End

2027-11-20

Status

activein 550 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_SAQMIP26GR0017_019.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.